» Articles » PMID: 1747954

Vascular Deposition of Complement-split Products in Kidney Allografts with Cell-mediated Rejection

Overview
Date 1991 Dec 1
PMID 1747954
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Complement activation in 73 renal transplant biopsies was investigated by indirect immunoperoxidase staining using MoAbs reactive with complement-split products. Intense deposition of complement fragments C4d and C3d in peritubular capillaries, indicating activation of the classical pathway, could be detected in the majority of transplanted kidneys with cell-mediated rejections. Abundant deposition of complement-split products was observed in 22 early biopsies from patients with high 'immunological risk' (i.e. previous, rejected transplants and/or circulating antibodies against HLA-antigens). Despite negative results in the crossmatch before transplantation and paucity of immunoglobulins in transplant biopsies, antibodies directed against endothelial cell antigens should be considered as a possible cause of classical complement activation.

Citing Articles

Animal models for transplant immunology: bridging bench to bedside.

Kang M, Park H, Kim K, Choi D Clin Transplant Res. 2024; 38(4):354-376.

PMID: 39233453 PMC: 11732767. DOI: 10.4285/ctr.24.0029.


Posttransplant complications: molecular mechanisms and therapeutic interventions.

Liu X, Shen J, Yan H, Hu J, Liao G, Liu D MedComm (2020). 2024; 5(9):e669.

PMID: 39224537 PMC: 11366828. DOI: 10.1002/mco2.669.


Risk and protection of different rare protein-coding variants of complement component C4A in age-related macular degeneration.

Seddon J, De D, Casazza W, Cheng S, Punzo C, Daly M Front Genet. 2024; 14:1274743.

PMID: 38348408 PMC: 10859408. DOI: 10.3389/fgene.2023.1274743.


Engineering human pluripotent stem cell lines to evade xenogeneic transplantation barriers.

Pizzato H, Alonso-Guallart P, Woods J, Connelly J, Fehniger T, Atkinson J Stem Cell Reports. 2024; 19(2):299-313.

PMID: 38215755 PMC: 10874864. DOI: 10.1016/j.stemcr.2023.12.003.


Therapy in the Course of Kidney Graft Rejection-Implications for the Cardiovascular System-A Systematic Review.

Mizera J, Pilch J, Giordano U, Krajewska M, Banasik M Life (Basel). 2023; 13(7).

PMID: 37511833 PMC: 10381422. DOI: 10.3390/life13071458.


References
1.
Terasaki P, MCCLELLAND J . MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS. Nature. 1964; 204:998-1000. DOI: 10.1038/204998b0. View

2.
BUSCH G, Reynolds E, GALVANEK E, Braun W, DAMMIN G . Human renal allografts. The role of vascular injury in early graft failure. Medicine (Baltimore). 1971; 50(1):29-83. View

3.
Arvieux J, Yssel H, Colomb M . Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. Immunology. 1988; 65(2):229-35. PMC: 1384918. View

4.
Mathew M, Bolton W . Linear C3 deposits on the tubular basement membrane in renal allograft biopsies. Am J Kidney Dis. 1988; 12(2):121-5. DOI: 10.1016/s0272-6386(88)80006-4. View

5.
Zwirner J, FELBER E, Herzog V, Riethmuller G, Feucht H . Classical pathway of complement activation in normal and diseased human glomeruli. Kidney Int. 1989; 36(6):1069-77. DOI: 10.1038/ki.1989.302. View